Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Dosage Form
3.4. Snippet by Sales Channel
3.5. Snippet by Distribution Channel
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Availability of New Treatments for Dry Eye Syndrome
4.1.1.2. Increasing Prevalence of Dry Eye Syndrome
4.1.2. Restraints
4.1.2.1. The High Cost of Dry Eye Treatments
4.1.3. Opportunity
4.1.3.1. Integration of Digital Health Solutions
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. By Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. Aqueous deficiency*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Evaporative
9. By Product
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.1.2. Market Attractiveness Index, By Product
9.2. Anti-inflammatory Drugs*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.2.3. Cyclosporine
9.2.4. Corticosteroid
9.2.5. Other
9.3. Lubricant Eye Drops
9.4. Punctal Plugs
9.4.1. Removable
9.4.2. Dissolvable
9.5. Oral Omega Supplements
9.6. Others
10. By Dosage Form
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
10.1.2. Market Attractiveness Index, By Dosage Form
10.2. Gels*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Eye Solutions
10.4. Capsules & Tablets
10.5. Eye Drops
10.6. Ointments
11. By Sales Channel
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
11.1.2. Market Attractiveness Index, By Sales Channel
11.2. Prescription*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. OTC
12. By Distribution Channel
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.1.2. Market Attractiveness Index, By Distribution Channel
12.2. Hospital Pharmacies*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Retail Pharmacies
12.4. Online Pharmacies
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
13.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
13.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form
13.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
13.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.2.8.1. The U.S.
13.2.8.2. Canada
13.2.8.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
13.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
13.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form
13.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
13.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.3.8.1. Germany
13.3.8.2. The U.K.
13.3.8.3. France
13.3.8.4. Italy
13.3.8.5. Spain
13.3.8.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
13.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
13.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form
13.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
13.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.4.8.1. Brazil
13.4.8.2. Argentina
13.4.8.3. Rest of South America
13.5. Asia Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
13.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
13.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form
13.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
13.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
13.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
13.5.8.1. China
13.5.8.2. India
13.5.8.3. Japan
13.5.8.4. Australia
13.5.8.5. Rest of Asia Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
13.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
13.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form
13.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
13.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies
15. Company Profiles
15.1. Novartis AG*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. AbbVie, Inc.
15.3. Sun Pharmaceutical Industries Ltd.
15.4. Santen Pharmaceutical Co., Ltd.
15.5. AFT Pharmaceuticals
15.6. Johnson & Johnson Services, Inc.
15.7. Otsuka Pharmaceutical Co., Ltd.
15.8. OASIS Medical.
15.9. Oyster Point Pharma, Inc.
15.10. Bausch & Lomb
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us